Issues & Advocacy
In 2013, several provisions of the Affordable Care Act (ACA) will be implemented impacting patients and all industries in the health care delivery system, and MDMA is once again at the forefront ensuring that the voice of our members and the medical technology community is heard. MDMA focuses on being not just the voice, but also the eyes and ears for its members regarding changes in the regulatory environment, reimbursement and all issues that impact our ability to innovate.
Continuing our proud tradition of leading the fight against the medical device tax since it was first proposed, MDMA championed the repeal efforts in the House of Representatives, which overwhelmingly voted on a bipartisan basis to end this policy last year. While Congress did not act to repeal the device tax prior to implementation, MDMA remains committed to building on the new momentum and support to address this challenge.
An understanding and awareness of the policy discussions taking place in Washington related to Congress, the Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS) and other federal agencies is a must for medical technology executives. the decisions made in Washington can impact your company for many years to come. Lack of participation is not an option for the long term viability of the entrepreneurial sector of the industry. For the past 20 years. MDMA has grown from a one issue organization to an effective advocate on every major issue affecting the innovative sector of the medical technology industry.
We invite all of our member companies to participate on one or more of MDMA’s Working Groups. These groups address the many challenges facing innovative medical device companies. Each working group meets monthly via conference call and receives additional email updates and breaking news on a consistent basis. Current MDMA Working Groups include:
- Coverage & Reimbursement
- Healthcare Reform Implementation (device tax)
- Market Access
If you are a MDMA member and would like to participate in a working group please email your participation prefernce and you will be added to the group.
Legislative Action Center
The importance of smaller companies being represented in Washington cannot be overstated. MDMA is constantly monitoring legislation and regulations that can impact the medical technology community, and consistently represents the collective interests of our membership. However, our ability to impact policy decisions is directly related to how much participation we have from our members. MDMA's Legislative Action Center provides tools which allow members to quickly and easily contact their elected officials, local and national media and colleagues in industry on important issues and pending legislation.